1. The background of Neurodegenerative diseases and the Current therapeutic approaches.
2. Effective delivery of therapeutic genes into target cells via AAV.
3. CRISPR/Cas13 system in RNA-editing;
4. The break through of RNA-editing in Neurodegenerative diseases treatment.
5. Future Perspectives of AAV-mediated gene therapy of Neurodegenerative diseases.